drugset / Trial / NCT00005056

Bryostatin 1 In Treating Patients With Progressive Kidney Cancer

NCT00005056

Phase 2 Completed Cancer Research UK
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of bryostatin 1 in treating patients who have progressive kidney cancer

Timeline

Start
1999-03
Primary completion
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject bryostatin 1 Small molecule Intravenous

Indications